BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 27941122)

  • 21. Regional dynamics of amyloid-β deposition in healthy elderly, mild cognitive impairment and Alzheimer's disease: a voxelwise PiB-PET longitudinal study.
    Villain N; Chételat G; Grassiot B; Bourgeat P; Jones G; Ellis KA; Ames D; Martins RN; Eustache F; Salvado O; Masters CL; Rowe CC; Villemagne VL;
    Brain; 2012 Jul; 135(Pt 7):2126-39. PubMed ID: 22628162
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of qualitative and quantitative imaging characteristics of [11C]PiB and [18F]flutemetamol in normal control and Alzheimer's subjects.
    Mountz JM; Laymon CM; Cohen AD; Zhang Z; Price JC; Boudhar S; McDade E; Aizenstein HJ; Klunk WE; Mathis CA
    Neuroimage Clin; 2015; 9():592-8. PubMed ID: 26640770
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MR, (18)F-FDG, and (18)F-AV45 PET correlate with AD PSEN1 original phenotype.
    Saint-Aubert L; Payoux P; Hannequin D; Barbeau EJ; Campion D; Delisle MB; Tafani M; Viallard G; Péran P; Puel M; Chollet F; Demonet JF; Pariente J
    Alzheimer Dis Assoc Disord; 2013; 27(1):91-4. PubMed ID: 22517194
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Positron emission tomography imaging in dementia.
    Herholz K; Carter SF; Jones M
    Br J Radiol; 2007 Dec; 80 Spec No 2():S160-7. PubMed ID: 18445746
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Discriminative Power of Arterial Spin Labeling Magnetic Resonance Imaging and 18F-Fluorodeoxyglucose Positron Emission Tomography Changes for Amyloid-β-Positive Subjects in the Alzheimer's Disease Continuum.
    Tosun D; Schuff N; Jagust W; Weiner MW;
    Neurodegener Dis; 2016; 16(1-2):87-94. PubMed ID: 26560336
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relationship between Alzheimer disease-like pattern of 18F-FDG and fasting plasma glucose levels in cognitively normal volunteers.
    Ishibashi K; Onishi A; Fujiwara Y; Ishiwata K; Ishii K
    J Nucl Med; 2015 Feb; 56(2):229-33. PubMed ID: 25572094
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Concordance between (99m)Tc-ECD SPECT and 18F-FDG PET interpretations in patients with cognitive disorders diagnosed according to NIA-AA criteria.
    Ito K; Shimano Y; Imabayashi E; Nakata Y; Omachi Y; Sato N; Arima K; Matsuda H
    Int J Geriatr Psychiatry; 2014 Oct; 29(10):1079-86. PubMed ID: 24687634
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rapid scanning protocol for brain (18)F-FDG PET: a validation study.
    Chen WP; Matsunari I; Noda A; Yanase D; Yajima K; Takeda N; Yamada M; Minoshima S; Nishimura S
    J Nucl Med; 2005 Oct; 46(10):1633-41. PubMed ID: 16204713
    [TBL] [Abstract][Full Text] [Related]  

  • 29. How the cognitive reserve interacts with β-amyloid deposition in mitigating FDG metabolism: An observational study.
    Carapelle E; Serra L; Modoni S; Falcone M; Caltagirone C; Bozzali M; Specchio LM; Avolio C
    Medicine (Baltimore); 2017 Apr; 96(16):e5876. PubMed ID: 28422821
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Feasibility of estimation of brain volume and 2-deoxy-2-(18)F-fluoro-D-glucose metabolism using a novel automated image analysis method: application in Alzheimer's disease.
    Musiek ES; Saboury B; Mishra S; Chen Y; Reddin JS; Newberg AB; Udupa JK; Detre JA; Hofheinz F; Torigian D; Alavi A
    Hell J Nucl Med; 2012; 15(3):190-6. PubMed ID: 23106049
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Brain and Brown Adipose Tissue Metabolism in Transgenic Tg2576 Mice Models of Alzheimer Disease Assessed Using
    Coleman RA; Liang C; Patel R; Ali S; Mukherjee J
    Mol Imaging; 2017 Jan; 16():1536012117704557. PubMed ID: 28654383
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detectability of hypometabolic regions in mild Alzheimer disease: function of time after the injection of 2-[fluorine 18]-fluoro-2-deoxy-D-glucose.
    Sakamoto S; Ishii K; Hosaka K; Mori T; Sasaki M; Mori E
    AJNR Am J Neuroradiol; 2005 Apr; 26(4):843-7. PubMed ID: 15814932
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular Imaging of Alzheimer's Disease-Related Sigma-1 Receptor in the Brain
    Bai P; Bagdasarian FA; Xu Y; Wang Y; Wang Y; Gomm A; Zhou Y; Wu R; Wey HY; Tanzi RE; Zhang C; Lan Y; Wang C
    J Med Chem; 2024 Apr; 67(8):6207-6217. PubMed ID: 38607332
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The use of the exploratory IND in the evaluation and development of 18F-PET radiopharmaceuticals for amyloid imaging in the brain: a review of one company's experience.
    Carpenter AP; Pontecorvo MJ; Hefti FF; Skovronsky DM
    Q J Nucl Med Mol Imaging; 2009 Aug; 53(4):387-93. PubMed ID: 19834448
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel Functional Renal PET Imaging With 18F-FDS in Human Subjects.
    Werner RA; Ordonez AA; Sanchez-Bautista J; Marcus C; Lapa C; Rowe SP; Pomper MG; Leal JP; Lodge MA; Javadi MS; Jain SK; Higuchi T
    Clin Nucl Med; 2019 May; 44(5):410-411. PubMed ID: 30762825
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vivo PET study of cerebral [11C] methyl- tetrahydroaminoacridine distribution and kinetics in healthy human subjects.
    Traykov L; Tavitian B; Jobert A; Boller F; Forette F; Crouzel C; Di Giamberardino L; Pappata S
    Eur J Neurol; 1999 May; 6(3):273-8. PubMed ID: 10210906
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [18F]FETO for adrenocortical PET imaging: a pilot study in healthy volunteers.
    Wadsak W; Mitterhauser M; Rendl G; Schuetz M; Mien LK; Ettlinger DE; Dudczak R; Kletter K; Karanikas G
    Eur J Nucl Med Mol Imaging; 2006 Jun; 33(6):669-72. PubMed ID: 16568205
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Covariance statistics and network analysis of brain PET imaging studies.
    Veronese M; Moro L; Arcolin M; Dipasquale O; Rizzo G; Expert P; Khan W; Fisher PM; Svarer C; Bertoldo A; Howes O; Turkheimer FE
    Sci Rep; 2019 Feb; 9(1):2496. PubMed ID: 30792460
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical and Technical Considerations for Brain PET Imaging for Dementia.
    Acuff SN; Mathotaarachchi S; Zukotynski K; Osborne D; Subramaniam R;
    J Nucl Med Technol; 2020 Mar; 48(1):5-8. PubMed ID: 31182663
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Performance of a ⁶²Zn/⁶²Cu microgenerator in kit-based synthesis and delivery of [⁶²Cu]Cu-ETS for PET perfusion imaging.
    Ng Y; Lacy JL; Fletcher JW; Green MA
    Appl Radiat Isot; 2014 Sep; 91():38-43. PubMed ID: 24886964
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.